Q60875: Rho guanine nucleotide exchange factor 2
Protein names | - Rho guanine nucleotide exchange factor 2 - Guanine nucleotide exchange factor H1 - GEF-H1 - LBC'S first cousin - Lymphoid blast crisis-like 1 - Oncogene LFC - Rhobin |
---|---|
Gene names | Arhgef2 |
Organism | Mus musculus |
Protease Family | |
Protease ID | |
Chromosome location | |
UniProt ID | Q60875 |
2
N-termini
2
C-termini
0
Cleavages
0
Substrates
Sequence
10 20 30 40 50 60
MSRIESLTRA RIDRSKEQAT KTREKEKMKE AKDARYTNGH LFTTISVSGM TMCYACNKSI
70 80 90 100 110 120
TAKEALICPT CNVTIHNRCK DTLANCTKVK QKQQKAALLR NNTALQSVSL RSKTTTRERP
130 140 150 160 170 180
TSAIYPSDSF RQSLLGSRRG LSSLSLAKSV STTNIAGHFN DESPLGLRQI LSQSTDSLNM
190 200 210 220 230 240
RNRTLSVESL IDEGVEVFYN ELMSDFEMDE KDFEADSWSL AVDSSFLQQH KKEVMKKQDV
250 260 270 280 290 300
IYELIQTELH HVRTLKIMTR LFRTGMLEEL QMEPEVVQGL FPCVDELSDI HTRFLNQLLE
310 320 330 340 350 360
RRRQALCPGS TRNFVIHRLG DLLISQFSGS NAEQMRKTYS EFCSRHTKAL KLYKELYARD
370 380 390 400 410 420
KRFQQFIRKM TRSAVLKRHG VQECILLVTQ RITKYPVLIN RILQNSHGVE EEYQDLASAL
430 440 450 460 470 480
GLVKELLSNV DQDVHELEKE ARLQEIYNRM DPRAQTPVPG KGPFGRDELL RRKLIHEGCL
490 500 510 520 530 540
LWKTATGRFK DVLLLLMTDV LVFLQEKDQK YIFTSLDKPS VVSLQNLIVR DIANQAKGMF
550 560 570 580 590 600
LISSGPPEMY EVHAASRDDR TTWIRVIQQS VRLCPSREDF PLIETEDKAY LRRIKTKLQQ
610 620 630 640 650 660
KNQALVELLQ KNVELFAEMV HFQALKAGFV GMPPPALPRG LFRLESFESL RGERLLKDAL
670 680 690 700 710 720
REVEGLKDLL LGPCVDLPMT SREPALPLDS DSGSCPGVTA NGEARTFNGS IELCRADSDS
730 740 750 760 770 780
SQKDRNGNQL RSPQEEVLQP LINLYGLLHG LQAVVVQQER LMEALFPEGP ERWEKLSRAN
790 800 810 820 830 840
SRDGEAGRAA VASVTPEKQA TELALLQRQH TLLQEELRRC QRLGEERATE AGSLEARLRE
850 860 870 880 890 900
SEQARALLER EAEEIRRQLA ALGQNEPLPA EAPWARRPLD PRRRSLPAGD ALYLSFNPPQ
910 920 930 940 950 960
PSRGHDRLDL PVTVRSLHRP FDDREAQELG SPEDRLQDSS DPDTGSEEEV SSRLSPPHSP
970 980
RDFTRMQDIP EETESRDGEP TASES
Isoforms
- Isoform 2 of Rho guanine nucleotide exchange factor 2 - Isoform 3 of Rho guanine nucleotide exchange factor 2 - Isoform 4 of Rho guanine nucleotide exchange factor 2 - Isoform 5 of Rho guanine nucleotide exchange factor 2Sequence View
10 20 30 40 50 60
MSRIESLTRA RIDRSKEQAT KTREKEKMKE AKDARYTNGH LFTTISVSGM TMCYACNKSI
70 80 90 100 110 120
TAKEALICPT CNVTIHNRCK DTLANCTKVK QKQQKAALLR NNTALQSVSL RSKTTTRERP
130 140 150 160 170 180
TSAIYPSDSF RQSLLGSRRG LSSLSLAKSV STTNIAGHFN DESPLGLRQI LSQSTDSLNM
190 200 210 220 230 240
RNRTLSVESL IDEGVEVFYN ELMSDFEMDE KDFEADSWSL AVDSSFLQQH KKEVMKKQDV
250 260 270 280 290 300
IYELIQTELH HVRTLKIMTR LFRTGMLEEL QMEPEVVQGL FPCVDELSDI HTRFLNQLLE
310 320 330 340 350 360
RRRQALCPGS TRNFVIHRLG DLLISQFSGS NAEQMRKTYS EFCSRHTKAL KLYKELYARD
370 380 390 400 410 420
KRFQQFIRKM TRSAVLKRHG VQECILLVTQ RITKYPVLIN RILQNSHGVE EEYQDLASAL
430 440 450 460 470 480
GLVKELLSNV DQDVHELEKE ARLQEIYNRM DPRAQTPVPG KGPFGRDELL RRKLIHEGCL
490 500 510 520 530 540
LWKTATGRFK DVLLLLMTDV LVFLQEKDQK YIFTSLDKPS VVSLQNLIVR DIANQAKGMF
550 560 570 580 590 600
LISSGPPEMY EVHAASRDDR TTWIRVIQQS VRLCPSREDF PLIETEDKAY LRRIKTKLQQ
610 620 630 640 650 660
KNQALVELLQ KNVELFAEMV HFQALKAGFV GMPPPALPRG LFRLESFESL RGERLLKDAL
670 680 690 700 710 720
REVEGLKDLL LGPCVDLPMT SREPALPLDS DSGSCPGVTA NGEARTFNGS IELCRADSDS
730 740 750 760 770 780
SQKDRNGNQL RSPQEEVLQP LINLYGLLHG LQAVVVQQER LMEALFPEGP ERWEKLSRAN
790 800 810 820 830 840
SRDGEAGRAA VASVTPEKQA TELALLQRQH TLLQEELRRC QRLGEERATE AGSLEARLRE
850 860 870 880 890 900
SEQARALLER EAEEIRRQLA ALGQNEPLPA EAPWARRPLD PRRRSLPAGD ALYLSFNPPQ
910 920 930 940 950 960
PSRGHDRLDL PVTVRSLHRP FDDREAQELG SPEDRLQDSS DPDTGSEEEV SSRLSPPHSP
970 980
RDFTRMQDIP EETESRDGEP TASES
10 20 30 40 50 60
MSRIESLTRA RIDRSKEQAT KTREKEKMKE AKDARYTNGH LFTTISVSGM TMCYACNKSI
70 80 90 100 110 120
TAKEALICPT CNVTIHNRCK DTLANCTKVK QKQQKAALLR NNTALQSVSL RSKTTTRERP
130 140 150 160 170 180
TSAIYPSDSF RQSLLGSRRG LSSLSLAKSV STTNIAGHFN DESPLGLRQI LSQSTDSLNM
190 200 210 220 230 240
RNRTLSVESL IDEGVEVFYN ELMSDFEMDE KDFEADSWSL AVDSSFLQQH KKEVMKKQDV
250 260 270 280 290 300
IYELIQTELH HVRTLKIMTR LFRTGMLEEL QMEPEVVQGL FPCVDELSDI HTRFLNQLLE
310 320 330 340 350 360
RRRQALCPGS TRNFVIHRLG DLLISQFSGS NAEQMRKTYS EFCSRHTKAL KLYKELYARD
370 380 390 400 410 420
KRFQQFIRKM TRSAVLKRHG VQECILLVTQ RITKYPVLIN RILQNSHGVE EEYQDLASAL
430 440 450 460 470 480
GLVKELLSNV DQDVHELEKE ARLQEIYNRM DPRAQTPVPG KGPFGRDELL RRKLIHEGCL
490 500 510 520 530 540
LWKTATGRFK DVLLLLMTDV LVFLQEKDQK YIFTSLDKPS VVSLQNLIVR DIANQAKGMF
550 560 570 580 590 600
LISSGPPEMY EVHAASRDDR TTWIRVIQQS VRLCPSREDF PLIETEDKAY LRRIKTKLQQ
610 620 630 640 650 660
KNQALVELLQ KNVELFAEMV HFQALKAGFV GMPPPALPRG LFRLESFESL RGERLLKDAL
670 680 690 700 710 720
REVEGLKDLL LGPCVDLPMT SREPALPLDS DSGSCPGVTA NGEARTFNGS IELCRADSDS
730 740 750 760 770 780
SQKDRNGNQL RSPQEEVLQP LINLYGLLHG LQAVVVQQER LMEALFPEGP ERWEKLSRAN
790 800 810 820 830 840
SRDGEAGRAA VASVTPEKQA TELALLQRQH TLLQEELRRC QRLGEERATE AGSLEARLRE
850 860 870 880 890 900
SEQARALLER EAEEIRRQLA ALGQNEPLPA EAPWARRPLD PRRRSLPAGD ALYLSFNPPQ
910 920 930 940 950 960
PSRGHDRLDL PVTVRSLHRP FDDREAQELG SPEDRLQDSS DPDTGSEEEV SSRLSPPHSP
970 980
RDFTRMQDIP EETESRDGEP TASES
10 20 30 40 50 60
MSRIESLTRA RIDRSKEQAT KTREKEKMKE AKDARYTNGH LFTTISVSGM TMCYACNKSI
70 80 90 100 110 120
TAKEALICPT CNVTIHNRCK DTLANCTKVK QKQQKAALLR NNTALQSVSL RSKTTTRERP
130 140 150 160 170 180
TSAIYPSDSF RQSLLGSRRG LSSLSLAKSV STTNIAGHFN DESPLGLRQI LSQSTDSLNM
190 200 210 220 230 240
RNRTLSVESL IDEGVEVFYN ELMSDFEMDE KDFEADSWSL AVDSSFLQQH KKEVMKKQDV
250 260 270 280 290 300
IYELIQTELH HVRTLKIMTR LFRTGMLEEL QMEPEVVQGL FPCVDELSDI HTRFLNQLLE
310 320 330 340 350 360
RRRQALCPGS TRNFVIHRLG DLLISQFSGS NAEQMRKTYS EFCSRHTKAL KLYKELYARD
370 380 390 400 410 420
KRFQQFIRKM TRSAVLKRHG VQECILLVTQ RITKYPVLIN RILQNSHGVE EEYQDLASAL
430 440 450 460 470 480
GLVKELLSNV DQDVHELEKE ARLQEIYNRM DPRAQTPVPG KGPFGRDELL RRKLIHEGCL
490 500 510 520 530 540
LWKTATGRFK DVLLLLMTDV LVFLQEKDQK YIFTSLDKPS VVSLQNLIVR DIANQAKGMF
550 560 570 580 590 600
LISSGPPEMY EVHAASRDDR TTWIRVIQQS VRLCPSREDF PLIETEDKAY LRRIKTKLQQ
610 620 630 640 650 660
KNQALVELLQ KNVELFAEMV HFQALKAGFV GMPPPALPRG LFRLESFESL RGERLLKDAL
670 680 690 700 710 720
REVEGLKDLL LGPCVDLPMT SREPALPLDS DSGSCPGVTA NGEARTFNGS IELCRADSDS
730 740 750 760 770 780
SQKDRNGNQL RSPQEEVLQP LINLYGLLHG LQAVVVQQER LMEALFPEGP ERWEKLSRAN
790 800 810 820 830 840
SRDGEAGRAA VASVTPEKQA TELALLQRQH TLLQEELRRC QRLGEERATE AGSLEARLRE
850 860 870 880 890 900
SEQARALLER EAEEIRRQLA ALGQNEPLPA EAPWARRPLD PRRRSLPAGD ALYLSFNPPQ
910 920 930 940 950 960
PSRGHDRLDL PVTVRSLHRP FDDREAQELG SPEDRLQDSS DPDTGSEEEV SSRLSPPHSP
970 980
RDFTRMQDIP EETESRDGEP TASES
10 20 30 40 50 60
MSRIESLTRA RIDRSKEQAT KTREKEKMKE AKDARYTNGH LFTTISVSGM TMCYACNKSI
70 80 90 100 110 120
TAKEALICPT CNVTIHNRCK DTLANCTKVK QKQQKAALLR NNTALQSVSL RSKTTTRERP
130 140 150 160 170 180
TSAIYPSDSF RQSLLGSRRG LSSLSLAKSV STTNIAGHFN DESPLGLRQI LSQSTDSLNM
190 200 210 220 230 240
RNRTLSVESL IDEGVEVFYN ELMSDFEMDE KDFEADSWSL AVDSSFLQQH KKEVMKKQDV
250 260 270 280 290 300
IYELIQTELH HVRTLKIMTR LFRTGMLEEL QMEPEVVQGL FPCVDELSDI HTRFLNQLLE
310 320 330 340 350 360
RRRQALCPGS TRNFVIHRLG DLLISQFSGS NAEQMRKTYS EFCSRHTKAL KLYKELYARD
370 380 390 400 410 420
KRFQQFIRKM TRSAVLKRHG VQECILLVTQ RITKYPVLIN RILQNSHGVE EEYQDLASAL
430 440 450 460 470 480
GLVKELLSNV DQDVHELEKE ARLQEIYNRM DPRAQTPVPG KGPFGRDELL RRKLIHEGCL
490 500 510 520 530 540
LWKTATGRFK DVLLLLMTDV LVFLQEKDQK YIFTSLDKPS VVSLQNLIVR DIANQAKGMF
550 560 570 580 590 600
LISSGPPEMY EVHAASRDDR TTWIRVIQQS VRLCPSREDF PLIETEDKAY LRRIKTKLQQ
610 620 630 640 650 660
KNQALVELLQ KNVELFAEMV HFQALKAGFV GMPPPALPRG LFRLESFESL RGERLLKDAL
670 680 690 700 710 720
REVEGLKDLL LGPCVDLPMT SREPALPLDS DSGSCPGVTA NGEARTFNGS IELCRADSDS
730 740 750 760 770 780
SQKDRNGNQL RSPQEEVLQP LINLYGLLHG LQAVVVQQER LMEALFPEGP ERWEKLSRAN
790 800 810 820 830 840
SRDGEAGRAA VASVTPEKQA TELALLQRQH TLLQEELRRC QRLGEERATE AGSLEARLRE
850 860 870 880 890 900
SEQARALLER EAEEIRRQLA ALGQNEPLPA EAPWARRPLD PRRRSLPAGD ALYLSFNPPQ
910 920 930 940 950 960
PSRGHDRLDL PVTVRSLHRP FDDREAQELG SPEDRLQDSS DPDTGSEEEV SSRLSPPHSP
970 980
RDFTRMQDIP EETESRDGEP TASES
Protein Neighborhood
Domains & Features
2 N-termini - 2 C-termini - 0 Cleavages - 0 Substrates
N-termini
Name | Sequence | Position | Modification | Evidence type | Method | Source (database) | Source (Lab) | Evidence name | Publications (PMID) |
---|---|---|---|---|---|---|---|---|---|
Q60875-1-unknown | MSRIES... | 1 | inferred from electronic annotation | electronic annotation | UniProtKB | inferred from uniprot | |||
Q60875-1-unknown | MSRIES... | 1 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt67382 | |||
Q60875-28-unknown | MKEAKD... | 28 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt67384 | |||
Q60875-28-unknown | MKEAKD... | 28 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt67385 | |||
Q60875-28-unknown | MKEAKD... | 28 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt98981 | |||
Q60875-28-unknown | MKEAKD... | 28 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TNt98982 |
C-termini
Name | Sequence | Position | Evidence type | Method | Source (database) | Source (Lab) | Evidence name | Publications (PMIDs) |
---|---|---|---|---|---|---|---|---|
...QSVRLC | 573 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt63000 | |||
...QSVRLC | 573 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt93065 | |||
...QSVRLC | 573 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt93066 | |||
...QSVRLC | 573 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt93067 | |||
...TASES | 985 | inferred from electronic annotation | electronic annotation | UniProtKB | inferred from uniprot | |||
...TASES | 985 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt63003 | |||
...TASES | 985 | inferred from isoform by sequence similarity | unknown | TopFIND | inferred from TCt63002 |
Cleavages
Protease | Position | Sequence | Evidence type | Method | Source (database) | Source (Lab) | Evidence name | Publications (PMIDs) |
---|
Substrates
Substrate | Position | Sequence | Evidence type | Method | Source (database) | Source (Lab) | Evidence name | Publications (PMIDs) |
---|